PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 108 filers reported holding PASSAGE BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,102 | -88.6% | 190,124 | -83.7% | 0.08% | -88.5% |
| Q2 2023 | $1,098,820 | -66.3% | 1,167,343 | -65.7% | 0.72% | -73.5% |
| Q1 2023 | $3,263,457 | -29.5% | 3,407,598 | +1.5% | 2.72% | -32.1% |
| Q4 2022 | $4,631,165 | +34.6% | 3,355,917 | +21.9% | 4.00% | +29.0% |
| Q3 2022 | $3,441,000 | +245.8% | 2,752,422 | +553.1% | 3.10% | +266.0% |
| Q2 2022 | $995,000 | +204.3% | 421,410 | +299.4% | 0.85% | +178.9% |
| Q1 2022 | $327,000 | – | 105,504 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |